Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 26, 2012 - Issue 4
322
Views
11
CrossRef citations to date
0
Altmetric
Short Communications

Antiproliferative activity of Luehea candicans Mart. et Zucc. (Tiliaceae)

, , , , , , , , & show all
Pages 364-369 | Received 11 Dec 2009, Accepted 05 Mar 2010, Published online: 22 Mar 2011
 

Abstract

Luehea candicans Mart. et Zucc. (Tiliaceae) is known as ‘açoita-cavalo’ and is one of the most important medicinal plants found in the Brazilian cerrado. The crude methanolic extracts of the branches and leaves and their fractions were evaluated using the following cancer cell lines: MCF-7 (breast), NCI-ADR (breast expressing the multidrug resistance phenotype), NCI-460 (lung), UACC-62 (melanoma), 786-0 (kidney), OVCAR (ovarian), PCO-3 (prostate), HT-29 (colon) and K-562 (leukaemia). The crude methanolic extracts from the branches (B) and leaves (L) were able to inhibit the growth of the K-562 and 786-0 cell lines in a dose-dependent manner, with GI50 values of 8.1 and 5.4 µg mL−1, respectively. The hexane (L1), chloroform (L2) and methanol (L4) fractions derived from extract L showed a high selectivity and pronounced cytostatic activity against 786-0 (GI50 ∼ 40 µg mL−1). A significant amount of lupeol was isolated from fraction L2. The chloroform (B2) and methanol (B3) fractions derived from extract (B) exhibited less selectivity, showing the highest cytostatic activity against K-562, NCI-ADR, OVCAR, MCF-7 and NCI-460 cells, with GI50 values between 27 and 40 µg mL−1. Lupeol, betulin, a mixture of steroids, (−)-epicatechin, vitexin and liriodendrin were isolated from these active fractions.

Acknowledgements

We are thankful to CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) for offering fellowship to VGA, DMMF, LCR and DAS. We also thank CNPq for providing financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.